Please login to the form below

Not currently logged in
Email:
Password:

HCV

This page shows the latest HCV news and features for those working in and with pharma, biotech and healthcare.

Gilead poaches Genentech-exec Merdad Parsey for its new CMO

Gilead poaches Genentech-exec Merdad Parsey for its new CMO

O’Day has revitalised Gilead since joining the company earlier this year, following a difficult few years as it faces a massive decline in sales of its hepatitis C virus (HCV) ... drugs. There has been concern that Gilead has been too reliant on its

Latest news

More from news
Approximately 8 fully matching, plus 119 partially matching documents found.

Latest Intelligence

  • Deal Watch October 2018

    HCV). As Gilead’s patent estate around these compounds is being challenged around the world, this appears to be a strategy of getting their response in first, and fending off both

  • Pharma deals in May 2015 Pharma deals in May 2015

    The agreement covers ACH 3102, ACH 3422 and sovaprevir. The intention is to trial a combination of ACH 3102 with a NS3/4A HCV protease inhibitor plus an NS5B HCV polymerase

  • AbbVie: New firm, new thinking AbbVie: New firm, new thinking

    virus (HCV) to help navigate the care system and make the most of new treatments. ... And obviously the NHS saves on downstream costs associated with HCV, such as liver disease and the prospect of liver transplants.

  • Communicating value Communicating value

    We are seeing instances, eg in HCV, where simple affordability, rather than cost effectiveness, is a major factor in spending decisions.

  • Deal Watch table for June 2014 Deal Watch table for June 2014

    42, 900. Idenix Pharmaceuticals/ Merck &Co. Company acquisition. Hepatitis C assets include IDX21437 (p1/2 nucleotide inhibitor) to combine with Merck HCV drugs. ... 75. Orion/ Bayer. Co-development, option to co-promote in Europe. OraQuick HCV rapid

More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 8 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

How do companies prepare for reimbursement?
Valid Insight explore how to optimise your market access strategy during new product development, how to address payer concerns and prepare for reimbursement....
EHR clinical trials
Integrating electronic health records into clinical trials
How organisations are working to realise the research potential of EHRs...
Mike Elliott Gilead
Keeping up the fight against HIV and using the lessons to tackle other threats
Danny Buckland interviews Gilead’s Mike Elliott...

Infographics